We are adding the following issues to the March recommended list.

We are recommending credit spreads in the following issues.

AZN - AstraZeneca plc discovers, develops, manufactures, and markets prescription pharmaceuticals and biological products in the areas of cardiovascular, gastrointestinal, neuroscience, oncology, respiratory and inflammation, and infection worldwide. Its primary products include Arimidex for hormonal breast cancer; Crestor that provides treatment for managing cholesterol levels; Nexium for acid-related diseases; Seroquel, an atypical anti-psychotic therapy for treating schizophrenia and bipolar mania; and Symbicort for the treatment of asthma in patients.

CSC - Computer Sciences Corporation (CSC) provides information technology (IT) and business process outsourcing, and IT and professional services to the commercial and government markets. The companyÂ’s information technology outsourcing services include the operation of customerÂ’s technology infrastructure, including systems analysis, applications development, network operations, desktop computing, and data center management. CSC also offers various business process outsourcing services, such as procurement and supply chain, call centers and customer relationship management, credit services, claims processing, and logistics.

we are recommending the following specific credit spreads.

Call credit spreads = bearish call spreads.

Supplemental ETF trades.

The following issues are a few additional candidates to supplement your search for profitable EFT and Index trades. As with any investment, you must decide if the selections meet your criteria for potential plays. Only you can know what strategies and positions are suitable for your experience level, risk-reward tolerance and individual outlook. There will be no commentary or analysis offered on these positions, nor will they be included in the MCM Portfolio.